A pioneering study from the Centre for Psychedelic Research at Imperial College London has revealed that psychedelics, such as magic mushrooms and LSD, can significantly improve sexual function for weeks or even months after the experience. Published in Nature Scientific Reports, this study is the first to scientifically explore how psychedelics influence sexual well-being, providing new insights that could have therapeutic implications for conditions like depression and anxiety.
Key Findings: Psychedelics Improve Sexual Function
The research, which analyzed responses from almost 300 participants, found that, on average, people reported notable improvements in several areas of sexual function after taking psychedelics. These included enhanced enjoyment of sex, sexual arousal, satisfaction, attraction to partners, body image and communication. These positive effects were observed up to six months after the psychedelic experience.
The study also involved a smaller group of participants taking psilocybin, the substance found in magic mushrooms, as part of a clinical trial for depression. Results showed that nearly half of these participants experienced improvements in sexual arousal, interest and satisfaction. In contrast, participants treated with the popular antidepressant escitalopram experienced a decline in sexual function, with 59% reporting sexual dysfunction by the end of the trial. Only 13% of those in the psilocybin group reported similar issues.
“We believe this is the first scientific study to explore the effects of psychedelics on sexual functioning,” said Tommaso Barba, the study's first author. “Our findings suggest potential implications for conditions that negatively affect sexual health, including clinical depression and anxiety.”
Potential For Treating Sexual Dysfunction
The study’s findings are particularly significant for individuals who suffer from sexual dysfunction due to antidepressants. Many antidepressants, including SSRIs like escitalopram, have well-known side effects that negatively impact sexual function. These side effects often lead patients to discontinue their medications, which can result in a relapse of depression. The positive effects of psilocybin on sexual well-being could offer an alternative treatment for these individuals, potentially alleviating sexual dysfunction without the need for conventional antidepressants.
Bruna Giribaldi, senior author of the paper, said that sexual side effects are often underreported in clinical trials. “We wanted to make sure we went deeper than that and explored more aspects of sexuality that could be impacted by these treatments.”
Study Limitations And Cautions
While the study’s findings are promising, there are some important limitations to consider. The data were gathered through questionnaires and the sample was largely composed of white, heterosexual, employed and well-educated individuals, which may limit the generalizability of the results. Additionally, the study did not examine sexual function during the psychedelic experience itself, but rather the lasting impacts after the substances had worn off.
The authors also cautioned against self-medicating with psychedelics, noting that the clinical trials involved professional psychological support and controlled dosing. “Psychedelic treatments were administered in a regulated, supportive environment, which is crucial for their therapeutic potential,” said Barba. “Patients with depression should not attempt to self-medicate with psychedelics.”
A New Frontier In Sexual Health?
These findings could have significant implications for treating sexual dysfunction, particularly in people with depression. While more research is needed, the study highlights the potential of psychedelics as a tool for improving sexual health and overall well-being. “Sexual dysfunction is linked to lower well-being in healthy adults, impacts relationship satisfaction, and is connected to subjective happiness and ‘meaning in life,” Barba concluded.
Cover image made with AI
